查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2089096

脊椎醫療設備和生物材料市場：2026-2032年全球市場預測（按產品類型、技術、應用、分銷管道和最終用戶分類）

Spinal Devices & Biologics Market by Product Category, Technology, Application, Distribution Channel, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，脊椎醫療設備和生物製藥市場將成長至 404.5 億美元，複合年成長率為 17.21%。

主要市場統計數據
基準年 2025 133億美元
預計年份：2026年 155.5億美元
預測年份 2032 404.5億美元
複合年成長率 (%) 17.21%

由於脊椎退化性疾病、創傷、畸形和癌症等因素導致的脊椎不穩定性在全球日益嚴重，脊椎醫療設備和生物製劑市場正在改變。世界衛生組織（WHO）的數據顯示，2020年全球有6.19億人患有背痛，預計2050年將達到8.43億人。這使得脊椎護理領域對醫院、門診手術中心、保險公司和醫療技術相關人員的需求持續旺盛。

人口老化、先進診斷影像技術的普及、微創脊椎手術的日益普及，以及脊椎固定裝置、活動度保留系統、導航植入物、骨移植替代植入、脫礦骨基質、細胞同種異體移植和合成生物製劑等領域的持續技術創新，共同推動了這一需求的成長。同時，實證醫學標準、價值導向的採購以及日益嚴格的監管要求製造商證明產品的安全性、固定性能、成本效益和實際臨床效用。

脊椎醫學領域的變革性變化

脊椎治療領域的格局正在轉變，從關注植入銷售轉向基於手術最佳化、治療效果證據和生物學見解的治療路徑。外科醫生和醫療系統優先考慮能夠縮短手術時間、提高植入放置精度、確保固定效果穩定以及降低再次手術風險的解決方案，而保險公司則越來越關注脊椎融合手術的適應症、生物製藥的高昂成本以及各臨床中心的成本效益。

人工智慧在脊椎醫學領域的累積影響

人工智慧 (AI) 正在對脊椎醫療設備和生物製藥的整個價值鏈產生累積影響。在術前規劃中，AI 驅動的影像分析可輔助分割、矢狀位排列評估、畸形測量和手術模擬。在手術中，導航和機器人平台利用數據豐富的流程輔助進行螺絲軌跡規劃和植入放置，而術後分析則有助於識別併發症、骨不連風險、再入院模式和復健需求。

主要區域洞察：亞太地區、北美地區、拉丁美洲地區、歐洲地區、中東和非洲地區

亞太地區擁有巨大的成長潛力，這主要得益於日本、中國、韓國和澳洲龐大的患者群體、快速發展的醫院基礎設施以及人口老化。同時，印度和東南亞地區獲得私人專科醫療服務和微創脊椎手術的機會也不斷增加。北美地區憑藉外科醫生積極採用先進技術、廣泛使用植入、FDA批准的技術、完善的保險報銷機制以及在脊椎手術中廣泛應用門診和日間手術中心模式，繼續保持其創新中心的地位。

東協、海灣合作理事會、歐盟、金磚國家、七國集團和北約的關鍵集團分析

東協市場受益於醫院現代化、區域醫療旅遊以及醫療設備註冊流程的逐步標準化，但成員國在定價、報銷和准入方面仍存在顯著差異。在海灣合作理事會（GCC）國家，政府主導的醫療改革、集中採購以及對複雜整形外科和神經外科能力的投資，推動了對高階脊椎技術的需求成長。

主要國家在主要脊椎治療市場的關鍵見解

美國憑藉其完善的FDA核准流程、大規模的醫院網路和高密度的專科醫生，已成為脊椎移植、生物製劑、導航、機器人技術和門診脊椎手術領域的主要創新中心。加拿大注重公共資金的取得、臨床有效性和成本效益，而墨西哥的市場則受國內需求以及跨境醫療服務和私立醫院發展的影響。巴西在整形外科和神經外科醫療體系方面領先拉丁美洲，其私人保險報銷、公共採購以及強大的分銷商網路蘊藏著巨大的商機。

為行業領導者提供的實用建議

產業領導者應優先考慮脊椎固定裝置、活動度保留系統和生物製劑的臨床證據、真實世界的治療效果和衛生經濟價值。能夠證明其產品具有固定性能、降低再次手術率、縮短住院時間、降低併發症風險和簡化工作流程等優勢的公司，將在基於價值的採購和保險公司審核中佔據更有利的地位。

調查方法

本調查方法採用三角測量法，結合二手調查、一手訪談和分析檢驗，得出脊椎醫療設備和生物材料的檢驗結論。資訊來源包括監管資料庫、產品授權和批准資訊、醫院採購指標、報銷政策、臨床指南、同行評審文獻、專利趨勢、不利事件資料庫以及世界衛生組織、經合組織、聯合國機構、美國食品藥物管理局和各國衛生部門等組織提供的公共衛生資料集。

結論

脊椎醫療設備和生物製藥市場正向更主導和數位化驅動的階段轉變。人口老化、背痛負擔加重以及先進脊椎手術的普及推動了市場需求，但監管和報銷壓力將導致臨床檢驗的解決方案與差異化程度有限的產品之間分化。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：脊椎醫療設備與生物材料市場：依產品類型

  • 生物製劑
    • 同種異體移植
    • 自體移植
    • 重組生長因子
    • 合成接枝
  • 醫療設備
    • 椎間融合
      • ALIF
      • PLIF
      • Tlif
      • Xlif
    • 椎弓骨釘系統
    • 椎板
    • 椎體壓迫性骨折

第8章：脊椎醫療設備與生物材料市場：依技術分類

  • 傳統開放式
  • 微創
  • 導航系統
  • 機器人技術

第9章：脊椎醫療設備與生物材料市場：依應用領域分類

  • 形變
  • 退化性疾病
  • 腫瘤學
  • 創傷

第10章：脊椎醫療設備與生物材料市場：依分銷管道分類

  • 直銷
  • 銷售代理
  • 電子商務

第11章：脊椎醫療設備與生物材料市場：依最終用戶分類

  • 門診手術中心
  • 診所
  • 醫院

第12章：脊椎醫療設備與生物材料市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章：脊椎醫療設備與生物材料市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：脊椎醫療設備與生物材料市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Alphatec Holdings, Inc.
  • Amedica Corporation
  • Arthrex, Inc.
  • B. Braun SE
  • Baxter International Inc.
  • Bioventus Inc.
  • Camber Spine Technologies, LLC
  • Companion Spine LLC
  • Cook Medical LLC
  • CTL Medical Corporation
  • Exactech, Inc.
  • Globus Medical, Inc.
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson
  • Kuros Biosciences AG
  • Medtronic plc
  • Orthofix Medical Inc.
  • Spineart SA
  • Spineology, Inc.
  • Stryker Corporation
  • W. Ulrich GmbH
  • Xtant Medical Holdings, Inc.
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-710B1F0AC641

The Spinal Devices & Biologics Market is projected to grow by USD 40.45 billion at a CAGR of 17.21% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 13.30 billion
Estimated Year [2026] USD 15.55 billion
Forecast Year [2032] USD 40.45 billion
CAGR (%) 17.21%

The spinal devices and biologics market is being reshaped by the global burden of degenerative spine disease, trauma, deformity, and cancer-related spinal instability. The World Health Organization reports that low back pain affected 619 million people in 2020 and is projected to affect 843 million people by 2050, making spine care a durable demand category for hospitals, ambulatory surgery centers, payers, and medical technology stakeholders.

Demand is supported by aging demographics, expanding access to advanced imaging, higher adoption of minimally invasive spine surgery, and continued innovation in spinal fusion devices, motion preservation systems, navigation-enabled implants, bone graft substitutes, demineralized bone matrices, cellular allografts, and synthetic biologics. At the same time, evidence standards, value-based procurement, and regulatory scrutiny are increasing, requiring manufacturers to demonstrate safety, fusion performance, cost-effectiveness, and real-world clinical utility.

Transformative Shifts in the Spine Care Landscape

The landscape is shifting from volume-led implant sales toward procedure optimization, outcomes evidence, and biologically informed care pathways. Surgeons and health systems are prioritizing solutions that reduce operating time, improve implant placement accuracy, support fusion consistency, and lower revision risk, while payers increasingly scrutinize indications for fusion, premium biologics, and site-of-care economics.

Minimally invasive techniques, expandable interbody cages, 3D-printed porous titanium, patient-specific planning, robotic guidance, and advanced graft materials are changing competitive differentiation. Regulatory frameworks such as the U.S. FDA 510(k), PMA, and biologics pathways, the European Union Medical Device Regulation, and country-specific reimbursement reviews are creating higher barriers for unsubstantiated claims and favoring manufacturers with strong clinical evidence, post-market surveillance, traceability, and quality systems.

Cumulative Impact of Artificial Intelligence in Spine Care

Artificial intelligence is producing a cumulative impact across the spinal devices and biologics value chain. In preoperative planning, AI-supported imaging can assist with segmentation, sagittal alignment assessment, deformity measurement, and surgical simulation. Intraoperatively, navigation and robotic platforms use data-rich workflows to support screw trajectory planning and implant placement, while postoperative analytics can help identify complications, nonunion risk, readmission patterns, and rehabilitation needs.

The U.S. FDA has documented a rapidly expanding universe of AI- and machine learning-enabled medical devices, with radiology and surgical planning among the most active categories. For spine technology developers, the near-term opportunity is not replacing clinical judgment but embedding AI into validated workflows that improve consistency, documentation, and decision support. Leaders will need transparent algorithms, cybersecurity controls, bias testing, interoperability, and evidence that AI-enabled tools improve measurable outcomes rather than simply adding capital cost.

Key Regional Insights: Asia-Pacific, North America, Latin America, Europe, Middle East, and Africa

Asia-Pacific is a high-potential region driven by large patient populations, fast-rising hospital infrastructure, and aging societies in Japan, China, South Korea, and Australia, while India and Southeast Asia expand access to private specialty care and minimally invasive spine procedures. North America remains an innovation anchor because of advanced surgeon adoption, strong implant utilization, FDA-cleared technologies, established reimbursement pathways, and extensive use of outpatient and ambulatory surgery center models for appropriate spine procedures.

Europe is shaped by mature clinical practice, aging populations, and stricter evidence requirements under the EU MDR, creating demand for proven spinal implants and biologics with robust post-market clinical data. Latin America, led by Brazil and Mexico, is expanding through private hospitals and medical tourism but remains sensitive to currency volatility, import dependence, and reimbursement limitations. The Middle East is investing in tertiary hospitals and specialty orthopedics, particularly across Gulf health systems, while Africa presents long-term access opportunities constrained by limited specialist capacity, infrastructure gaps, affordability barriers, and uneven availability of advanced spine surgery.

Key Group Insights Across ASEAN, GCC, European Union, BRICS, G7, and NATO

ASEAN markets are benefiting from hospital modernization, regional medical tourism, and gradual alignment of medical device registration practices, although pricing, reimbursement, and access vary widely across member states. The GCC is increasing demand for premium spine technologies through government-backed healthcare transformation, centralized procurement, and investments in complex orthopedic and neurosurgical capacity.

The European Union is prioritizing safety, traceability, clinical evaluation, and post-market surveillance under MDR, creating advantages for manufacturers with compliant technical documentation and post-market clinical follow-up. BRICS countries represent scale, manufacturing localization, and rising middle-class demand, but require country-specific pricing, tendering, and regulatory strategies. G7 markets continue to lead in R&D intensity, surgeon training, reimbursement sophistication, and clinical adoption, while NATO countries are placing greater emphasis on supply chain resilience, trauma readiness, cybersecurity, and secure medical technology sourcing.

Key Country Insights Across Major Spine Care Markets

The United States is the leading innovation hub for spinal implants, biologics, navigation, robotics, and outpatient spine procedures, supported by FDA pathways, large hospital networks, and strong specialist density. Canada emphasizes publicly funded access, clinical appropriateness, and cost-effectiveness, while Mexico combines domestic demand with cross-border care and private hospital growth. Brazil leads Latin America in orthopedic and neurosurgical capacity, with opportunities tied to private reimbursement, public procurement, and distributor strength.

In Europe, the United Kingdom, Germany, France, Italy, and Spain are mature spine care markets shaped by aging populations, surgeon expertise, national health technology assessment processes, and tightening value expectations, while Russia remains influenced by localization, procurement dynamics, and access variability. China is scaling domestic manufacturing and volume-based procurement, India is expanding private spine centers and affordability-focused implants, Japan prioritizes elderly spine care and precision technologies, Australia supports high-quality specialist care through advanced hospital networks, and South Korea is recognized for advanced hospitals, rapid technology adoption, and regional medical tourism.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinical evidence, real-world outcomes, and health economic value for spinal fusion devices, motion preservation systems, and biologics. Companies that can document fusion performance, revision reduction, shorter length of stay, lower complication risk, and workflow efficiency will be better positioned in value-based procurement and payer review.

Manufacturers should build differentiated portfolios around minimally invasive access, expandable and 3D-printed implants, biologics with defensible science, navigation compatibility, and AI-enabled planning. Regional strategies should combine premium innovation in G7 markets with affordability, localization, tender readiness, and distributor excellence in BRICS, ASEAN, Latin America, the Middle East, and Africa. Compliance, post-market surveillance, cybersecurity, supply chain resilience, and surgeon education must be treated as strategic assets rather than operational requirements.

Research Methodology

The research methodology applies triangulated secondary research, primary interviews, and analytical validation to develop verified insights on spinal devices and biologics. Sources include regulatory databases, product clearances and approvals, hospital procurement indicators, reimbursement policies, clinical guidelines, peer-reviewed literature, patent activity, adverse event databases, and public health datasets from institutions such as WHO, OECD, UN agencies, the U.S. FDA, and national health authorities.

Assumptions are validated through expert discussions with manufacturers, distributors, surgeons, procurement leaders, payers, regulatory professionals, and clinical specialists. The analysis evaluates product categories, technology adoption, regional demand drivers, pricing pressures, supply chain risks, competitive positioning, quality requirements, and evidence standards to ensure that insights are commercially relevant and grounded in verifiable data.

Conclusion

The spinal devices and biologics market is entering a more evidence-driven and digitally enabled phase. Demographic aging, the rising burden of low back pain, and expanding access to advanced spine surgery will sustain demand, while regulatory and reimbursement pressure will separate clinically validated solutions from products with limited differentiation.

The strongest competitors will integrate implant engineering, biologic science, AI-enabled planning, navigation, real-world evidence, cybersecurity, and region-specific market access strategies. Success will depend on proving measurable value for surgeons, hospitals, payers, and patients across both mature and emerging spine care systems.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Spinal Devices & Biologics Market, by Product Category

  • 7.1. Biologics
    • 7.1.1. Allografts
    • 7.1.2. Autografts
    • 7.1.3. Recombinant Growth Factors
    • 7.1.4. Synthetic Grafts
  • 7.2. Devices
    • 7.2.1. Interbody Fusion
      • 7.2.1.1. Alif
      • 7.2.1.2. Plif
      • 7.2.1.3. Tlif
      • 7.2.1.4. Xlif
    • 7.2.2. Pedicle Screw Systems
    • 7.2.3. Spinal Plates
    • 7.2.4. Vertebral Compression Fracture

8. Spinal Devices & Biologics Market, by Technology

  • 8.1. Conventional Open
  • 8.2. Minimally Invasive
  • 8.3. Navigation Systems
  • 8.4. Robotics

9. Spinal Devices & Biologics Market, by Application

  • 9.1. Deformity
  • 9.2. Degenerative
  • 9.3. Oncology
  • 9.4. Trauma

10. Spinal Devices & Biologics Market, by Distribution Channel

  • 10.1. Direct Sales
  • 10.2. Distributors
  • 10.3. Ecommerce

11. Spinal Devices & Biologics Market, by End User

  • 11.1. Ambulatory Surgery Centers
  • 11.2. Clinics
  • 11.3. Hospitals

12. Spinal Devices & Biologics Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Spinal Devices & Biologics Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Spinal Devices & Biologics Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Alphatec Holdings, Inc.
  • 16.2. Amedica Corporation
  • 16.3. Arthrex, Inc.
  • 16.4. B. Braun SE
  • 16.5. Baxter International Inc.
  • 16.6. Bioventus Inc.
  • 16.7. Camber Spine Technologies, LLC
  • 16.8. Companion Spine LLC
  • 16.9. Cook Medical LLC
  • 16.10. CTL Medical Corporation
  • 16.11. Exactech, Inc.
  • 16.12. Globus Medical, Inc.
  • 16.13. Integra LifeSciences Holdings Corporation
  • 16.14. Johnson & Johnson
  • 16.15. Kuros Biosciences A.G.
  • 16.16. Medtronic plc
  • 16.17. Orthofix Medical Inc.
  • 16.18. Spineart SA
  • 16.19. Spineology, Inc.
  • 16.20. Stryker Corporation
  • 16.21. W. Ulrich GmbH
  • 16.22. Xtant Medical Holdings, Inc.
  • 16.23. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BIOLOGICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BIOLOGICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ALLOGRAFTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ALLOGRAFTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ALLOGRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL AUTOGRAFTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL AUTOGRAFTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL AUTOGRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL RECOMBINANT GROWTH FACTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL RECOMBINANT GROWTH FACTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL RECOMBINANT GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SYNTHETIC GRAFTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SYNTHETIC GRAFTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SYNTHETIC GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL INTERBODY FUSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL INTERBODY FUSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL INTERBODY FUSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ALIF MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ALIF MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ALIF MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PLIF MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PLIF MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PLIF MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL TLIF MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL TLIF MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL TLIF MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL XLIF MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL XLIF MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL XLIF MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PEDICLE SCREW SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PEDICLE SCREW SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PEDICLE SCREW SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SPINAL PLATES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SPINAL PLATES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SPINAL PLATES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL VERTEBRAL COMPRESSION FRACTURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL VERTEBRAL COMPRESSION FRACTURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL VERTEBRAL COMPRESSION FRACTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CONVENTIONAL OPEN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CONVENTIONAL OPEN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CONVENTIONAL OPEN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MINIMALLY INVASIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MINIMALLY INVASIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MINIMALLY INVASIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL NAVIGATION SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL NAVIGATION SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL NAVIGATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ROBOTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ROBOTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ROBOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL DEFORMITY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL DEFORMITY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL DEFORMITY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL DEGENERATIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL DEGENERATIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL DEGENERATIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL TRAUMA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL TRAUMA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL TRAUMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL DIRECT SALES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL DIRECT SALES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL DIRECT SALES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL DISTRIBUTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL DISTRIBUTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL DISTRIBUTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ECOMMERCE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ECOMMERCE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ECOMMERCE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 130. MIDDLE EAST SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 140. AFRICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 149. ASEAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 151. ASEAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2018-2032 (USD MILLION)
  • TABLE 152. ASEAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 153. ASEAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. ASEAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 155. ASEAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. GCC SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 157. GCC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 158. GCC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 159. GCC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 160. GCC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2018-2032 (USD MILLION)
  • TABLE 161. GCC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 162. GCC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. GCC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. GCC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPEAN UNION SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPEAN UNION SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPEAN UNION SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPEAN UNION SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPEAN UNION SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPEAN UNION SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPEAN UNION SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPEAN UNION SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPEAN UNION SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 176. BRICS SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 177. BRICS SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 178. BRICS SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2018-2032 (USD MILLION)
  • TABLE 179. BRICS SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 180. BRICS SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. BRICS SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 182. BRICS SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. G7 SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 184. G7 SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 185. G7 SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 186. G7 SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 187. G7 SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2018-2032 (USD MILLION)
  • TABLE 188. G7 SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 189. G7 SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. G7 SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 191. G7 SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. NATO SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 193. NATO SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 194. NATO SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 195. NATO SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 196. NATO SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2018-2032 (USD MILLION)
  • TABLE 197. NATO SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 198. NATO SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. NATO SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 200. NATO SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. UNITED STATES SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 203. UNITED STATES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 204. UNITED STATES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 205. UNITED STATES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 206. UNITED STATES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2018-2032 (USD MILLION)
  • TABLE 207. UNITED STATES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 208. UNITED STATES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 209. UNITED STATES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 210. UNITED STATES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 211. CANADA SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 212. CANADA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 213. CANADA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 214. CANADA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 215. CANADA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2018-2032 (USD MILLION)
  • TABLE 216. CANADA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 217. CANADA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 218. CANADA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 219. CANADA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 220. MEXICO SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 221. MEXICO SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 222. MEXICO SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 223. MEXICO SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 224. MEXICO SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2018-2032 (USD MILLION)
  • TABLE 225. MEXICO SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 226. MEXICO SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 227. MEXICO SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 228. MEXICO SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. BRAZIL SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 230. BRAZIL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 231. BRAZIL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 232. BRAZIL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 233. BRAZIL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2018-2032 (USD MILLION)
  • TABLE 234. BRAZIL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 235. BRAZIL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 236. BRAZIL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 237. BRAZIL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED KINGDOM SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED KINGDOM SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED KINGDOM SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED KINGDOM SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED KINGDOM SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED KINGDOM SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED KINGDOM SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED KINGDOM SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED KINGDOM SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 247. GERMANY SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 248. GERMANY SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 249. GERMANY SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 250. GERMANY SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 251. GERMANY SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2018-2032 (USD MILLION)
  • TABLE 252. GERMANY SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 253. GERMANY SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 254. GERMANY SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 255. GERMANY SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 256. FRANCE SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 257. FRANCE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 258. FRANCE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 259. FRANCE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 260. FRANCE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2018-2032 (USD MILLION)
  • TABLE 261. FRANCE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 262. FRANCE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 263. FRANCE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 264. FRANCE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 265. RUSSIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 266. RUSSIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 267. RUSSIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 268. RUSSIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 269. RUSSIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2018-2032 (USD MILLION)
  • TABLE 270. RUSSIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 271. RUSSIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 272. RUSSIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 273. RUSSIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 274. ITALY SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 275. ITALY SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 276. ITALY SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 277. ITALY SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 278. ITALY SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2018-2032 (USD MILLION)
  • TABLE 279. ITALY SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 280. ITALY SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 281. ITALY SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 282. ITALY SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 283. SPAIN SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 284. SPAIN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 285. SPAIN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 286. SPAIN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 287. SPAIN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2018-2032 (USD MILLION)
  • TABLE 288. SPAIN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 289. SPAIN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 290. SPAIN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 291. SPAIN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 292. CHINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 293. CHINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 294. CHINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 295. CHINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 296. CHINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2018-2032 (USD MILLION)
  • TABLE 297. CHINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 298. CHINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 299. CHINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 300. CHINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 301. INDIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 302. INDIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 303. INDIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 304. INDIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 305. INDIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2018-2032 (USD MILLION)
  • TABLE 306. INDIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 307. INDIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 308. INDIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 309. INDIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 310. JAPAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 311. JAPAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 312. JAPAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 313. JAPAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 314. JAPAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2018-2032 (USD MILLION)
  • TABLE 315. JAPAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 316. JAPAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 317. JAPAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 318. JAPAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 319. AUSTRALIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 320. AUSTRALIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 321. AUSTRALIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 322. AUSTRALIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 323. AUSTRALIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2018-2032 (USD MILLION)
  • TABLE 324. AUSTRALIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 325. AUSTRALIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 326. AUSTRALIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 327. AUSTRALIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 328. SOUTH KOREA SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 329. SOUTH KOREA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 330. SOUTH KOREA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 331. SOUTH KOREA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 332. SOUTH KOREA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2018-2032 (USD MILLION)
  • TABLE 333. SOUTH KOREA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 334. SOUTH KOREA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 335. SOUTH KOREA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 336. SOUTH KOREA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)